对JAK/STAT信号通路的抑制表明,在尾中对乙溶解有保护作用
Farzan Solimani1,2, Julia Holstein3, Katharina Meier1
1Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Inflammation
|January 6, 2026
概括
,一种自身免疫性泡性疾病,涉及到针对desmoglein 3 (Dsg3) 的自身抗体. 这项研究表明,雅努斯激酶 (JAK) 抑制剂阻断了Dsg3自身抗体诱导的炎症和角质细胞中的细胞解离.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 杆菌是一种严重的自身免疫性水泡性疾病,影响皮肤和粘膜.
- 对德斯莫格林3 (Dsg3) 的自身抗体会导致角质细胞的附着性丧失 (乙溶解),导致水泡和侵蚀.
- 角质细胞可以在应对机械压力时产生炎症性细胞因子,这表明自身抗体结合可能会引发类似的反应.
研究的目的:
- 为了研究用抗Dsg抗体治疗的人类表皮角质细胞的细胞因子反应.
- 评估信号传感器和转录激活因子 (STAT) 和氏激酶 (JAK) 抑制剂在抗Dsg抗体诱导作用中的作用.
- 评估JAK抑制剂在尾虫中的治疗潜力.
主要方法:
- 定量基因表达 (qPCR) 用于分析细胞因子表达.
- 西方涂抹和基因表达试验用于研究STAT因子激活和JAK抑制剂的影响.
- 排放试验用于评估角质细胞解离和免疫组织化学,以评估皮肤活检中的STAT激活.
主要成果:
- 抗Dsg抗体治疗增加了细胞因子 (IL6,IL19,IL24,IFNE) 的表达.
- 反Dsg抗体激活了STAT1和STAT3信号通路.
- 雅克抑制剂在体外和体内都阻止了抗Dsg抗体诱导的STAT激活和角质细胞解离.
- 局部鲁克索利提尼布治疗在对类固醇不反应的尾虫患者中显示出临床改善,降低了表皮STAT激活.
结论:
- 皮体内表皮完整性的损失与细胞因子表达的增加有关.
- STAT信号通路由抗Dsg抗体激活,并有助于角质细胞解离.
- 雅克抑制剂通过抑制STAT激活和防止细胞解离,代表了对尾虫有前途的治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Amplifying Signals via Enzymatic Cascade
17.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.2K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K

